DJO® Showcases Growing Foot & Ankle Portfolio at ACFAS Scientific Conference
Through Recent Acquisitions and Internal Development, DJO makes its mark in the industry as a Foot & Ankle Business
DALLAS–(BUSINESS WIRE)–#acfas–DJO®, a subsidiary of Colfax Corporation (NYSE: CFX) and a leading global provider of medical technologies to get and keep people moving, today announced it will showcase their growing Foot & Ankle offerings at the 2022 American College of Foot and Ankle Surgeons (ACFAS) Scientific Conference in Austin from February 21-24, 2022. DJO has created a dedicated foot and ankle business unit that expands the company’s mission of Powering Motion.
“The last 14 months have been focused on building an intentional set of Foot & Ankle offerings through acquisitions and internal development here at DJO and now, we are ready to introduce ourselves as a Foot & Ankle division in one of the fastest growing markets of orthopedics,” said Gary Justak, President and General Manager of DJO’s Foot & Ankle Division. “We are here to provide disruptive innovation, share our proven outcomes and listen to the Foot & Ankle surgeon for continuous improvement and development opportunities.”
DJO will highlight products from their foot and ankle continuum of care including:
- DynaNail Hybrid™ Compressive power and stability of a nail with the easy insertion and anatomical friendliness of a screw.
- DynaClip® – Nitinol Compression Staples
- Arsenal Foot Plating System™: variable angle locking technology and dual lead screws
- STAR® Total Ankle Replacement
- Aircast ® AirSelect™ Walking Boot
- DJO® Regeneration OL1000™ Bone Stimulation Device
ACFAS Attendees have several opportunities throughout the week to experience these product offerings firsthand. Join one of the morning Industry Workshops, attend our Friday event customer event at The Eleanor Room, and visit Booth 104 in the Exhibit Hall. Registration links and more information can be found here: https://www.djoglobal.com/acfas
About DJO
DJO, a subsidiary of Colfax Corporation (NYSE:CFX), is a leading developer and distributor of high-quality medical devices that provide proven solutions for musculoskeletal health, joint reconstruction, vascular health, and pain management. The Company’s extensive range of products and integrated technologies address the orthopedic continuum of care from performance and mobility to surgical intervention and post-operative rehabilitation, enabling people around the world to regain or maintain their natural motion. For additional information about DJO, please visit www.DJOGlobal.com.
MK-10236
Contacts
DJO Contact:
Megan Foltz
[email protected]
